{"id":"technetium99","safety":{"commonSideEffects":[{"rate":null,"effect":"Radiation exposure"},{"rate":"rare","effect":"Allergic reaction to radiopharmaceutical preparation"}]},"_chembl":{"chemblId":"CHEMBL1200797","moleculeType":"Small molecule","molecularWeight":"281.13"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Technetium-99m is a metastable isotope of technetium that decays by isomeric transition, emitting gamma rays detectable by gamma cameras and SPECT systems. It is conjugated to various radiopharmaceutical compounds that target specific organs or pathological processes, enabling diagnostic imaging of perfusion, function, and pathology. The short half-life (6 hours) and favorable radiation dosimetry make it ideal for clinical nuclear medicine applications.","oneSentence":"Technetium-99m is a radioactive tracer that emits gamma radiation, allowing visualization of specific tissues and organs through nuclear imaging.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:42.594Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Myocardial perfusion imaging"},{"name":"Bone scintigraphy"},{"name":"Renal imaging"},{"name":"Hepatobiliary imaging"},{"name":"Lung ventilation/perfusion imaging"}]},"trialDetails":[{"nctId":"NCT06223659","phase":"PHASE2","title":"EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-12-19","conditions":"Cutaneous Melanoma, Merkel Cell Carcinoma, Skin Squamous Cell Carcinoma","enrollment":100},{"nctId":"NCT07441733","phase":"NA","title":"Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients","status":"RECRUITING","sponsor":"Casa di Cura Dott. Pederzoli","startDate":"2024-11-07","conditions":"Breast Cancer","enrollment":40},{"nctId":"NCT07146295","phase":"NA","title":"Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer","status":"RECRUITING","sponsor":"Isabelle Henskens","startDate":"2025-04-18","conditions":"Breast Cancer, Sentinel Lymph Node Biopsy (SLNB), Sentinel Lymph Node Detection","enrollment":1760},{"nctId":"NCT03545256","phase":"NA","title":"Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2018-05-31","conditions":"Cancer T1-N0 or T2-N0 of the Oral Cavity","enrollment":25},{"nctId":"NCT06378944","phase":"","title":"Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer","status":"RECRUITING","sponsor":"Omphis Foundation","startDate":"2024-01-01","conditions":"Breast Cancer","enrollment":15000},{"nctId":"NCT06024213","phase":"","title":"A French Observational Study of Indocyanine Green for Patients With Breast Cancer Having a Sentinel Lymph Node Biopsy.","status":"COMPLETED","sponsor":"BTG International Inc.","startDate":"2023-06-06","conditions":"Breast Cancer","enrollment":101},{"nctId":"NCT05625698","phase":"NA","title":"Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2021-10-01","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT06169072","phase":"PHASE2","title":"Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2023-01-01","conditions":"Breast Cancer, Sentinel Lymph Node","enrollment":220},{"nctId":"NCT06149884","phase":"","title":"Micrometastases in Axillary Lymph Nodes in Breast Cancer, Post-neoadjuvant Chemotherapy","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2006-09-01","conditions":"Micrometastases, Neoadjuvant Chemotherapy","enrollment":978},{"nctId":"NCT02997553","phase":"PHASE3","title":"Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery","status":"COMPLETED","sponsor":"Institut de Cancérologie de Lorraine","startDate":"2017-11-29","conditions":"Breast Carcinoma, Head and Neck Cancer, Melanoma (Skin)","enrollment":744},{"nctId":"NCT04577950","phase":"NA","title":"A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2021-01-21","conditions":"Endometrial Cancer","enrollment":120},{"nctId":"NCT03109522","phase":"NA","title":"Axillary Reverse Mapping (ARM) Technique","status":"UNKNOWN","sponsor":"McMaster University","startDate":"2016-11","conditions":"Invasive Breast Cancer, Ductal Carcinoma in Situ of the Breast","enrollment":130},{"nctId":"NCT03900104","phase":"NA","title":"Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-05-01","conditions":"Endometrial Cancer, Sentinel Lymph Node","enrollment":81},{"nctId":"NCT02543775","phase":"NA","title":"Sentinel Lymph Node Detection in Early Cervical Cancer","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2010-07","conditions":"Cervical Cancer","enrollment":75},{"nctId":"NCT02279108","phase":"PHASE3","title":"Study Assessing The Interest of Indocyanine Green Fluorescence Imaging With Radioisotope Method For Sentinel Lymph Node Biopsy in Patients With Breast Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2014-11","conditions":"Breast Neoplasms","enrollment":99},{"nctId":"NCT02057393","phase":"NA","title":"Infrared Lymphangiography as a Method of Sentinel Node Identification","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2014-06","conditions":"Melanoma, Sentinel Node","enrollment":89},{"nctId":"NCT00575744","phase":"PHASE2","title":"Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"1998-12","conditions":"Breast Cancer","enrollment":699},{"nctId":"NCT00089310","phase":"NA","title":"Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2004-09","conditions":"Lung Cancer","enrollment":46},{"nctId":"NCT02047240","phase":"","title":"Renal Function Determination in Patients With Liver Cirrhosis","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2013-04","conditions":"Liver Cirrhosis","enrollment":92},{"nctId":"NCT01179230","phase":"","title":"Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT","status":"COMPLETED","sponsor":"Hartford Hospital","startDate":"2005-01","conditions":"Coronary Artery Disease, Myocardial Ischemia, Heart Disease","enrollment":136},{"nctId":"NCT01564264","phase":"NA","title":"Sentinel Node Biopsy in Endometrial Cancer","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2012-11","conditions":"Uterine Neoplasms, Sentinel Lymph Node Biopsy","enrollment":50},{"nctId":"NCT02148666","phase":"","title":"Study of Homing of Labelled Stem Cells in Human Heart.","status":"UNKNOWN","sponsor":"All India Institute of Medical Sciences","startDate":"2014-08","conditions":"Homing of Stem Cells in the Infarct Area.","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":796,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Technetium99 sulfur colloid","NANOCIS"],"phase":"phase_3","status":"active","brandName":"Technetium99","genericName":"Technetium99","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Technetium-99m is a radioactive tracer that emits gamma radiation, allowing visualization of specific tissues and organs through nuclear imaging. Used for Myocardial perfusion imaging, Bone scintigraphy, Renal imaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}